Australian Corporate Flu Vaccination Services
A leading provider of workplace flu vaccinations and pharmacy vouchers in Australia
Now providing health check vouchers - a great option for small offices, remote workers, shift workers and more.
Now taking bookings for 2024
About Australian Vaccine Services
Australian Vaccine Services (AVS) is one of Australia’s leading specialist corporate flu vaccination services and one of the limited authorised organisations that can administer onsite corporate Covid-19 vaccination programs under the Department of Health’s National Vaccine Administration Partners Program (VAPP).
AVS completed over 281,000 onsite vaccinations and Pharmacy Vouchers across more than 4,090 locations nationally in 2023. Each year we work with a range of clients from Federal, State and Local Government departments, Enterprise, large, medium and small businesses, Universities, Councils, and non-for-profits.
*Note: Depending on the number of onsite vaccinations required, the QLD Government will subsidise up to 100% of the cost of AVS’s service. For clients of 59 onsite vaccinations or less, they may incur a small admin fee (to cover the admin/account management/online booking form etc.). The Departments of Health NSW, TAS, SA, VIC and NT have confirmed with us that they do not have plans to fund free vaccinations in their states. Contact our team to find out more.
One of the largest onsite corporate vaccination providers in Australia
National coverage (metro and regional)
Onsite flu vaccination program and Pharmacy Flu Voucher partnership with multiple major chains
Established in 2012, we have administered hundreds of thousands of vaccinations across thousands of sites
Australian based team employing local nurses
Our Flu Vaccination Clients Include
Client Testimonials
Protect against flu related losses in terms of unplanned absences, sick leave, and reduced productivity.
*This is an estimate only
Our Flu Vaccination Program Includes
Influenza Vaccination Strain 2024
Each year, the World Health Organization (WHO) puts forward its recommendations for the composition of influenza virus vaccine for the Southern Hemisphere influenza season.
It is recommended that quadrivalent vaccines for use in the 2024 Southern Hemisphere influenza season contain the following:
Egg-based quadrivalent influenza vaccines:
- an A/Wisconsin/67/2022 (H1N1)pdm09-like virus
- an A/Massachusetts/18/2022 (H3N2)-like virus
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus
- a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus
Egg-based Quadrivalent influenza vaccines is AVS standardised vaccine for 2024 flu season.
Get a 2024 vaccination program and health and wellness quote for your workplace!
If you would like to receive a quote for your 2024 corporate COVID-19 and flu vaccination program, Pharmacy Flu Vouchers, Skin and Health Checks for staff, please complete the enquiry form below. We will be in touch with your quote.
Latest News
Australia Grapples with Severe Flu Season
As the Southern Hemisphere winter grips Australia, the nation has faced an alarming peak in influenza cases at the end of June, marking a significant delay of two weeks compared to the previous year. This surge has placed the 2023
New Omicron Variant is one of the Most Infection Diseases Ever Known
A new Omicron variant (BA.2), now responsible for 80% of the UK Omicron cases, is at risk of causing a nationwide case surge during Autumn. However, it is confirmed that the vaccines and antiviral medication is just as effective on
Scrapping Isolation for COVID-19 Household Contacts
Household contacts of a positive COVID-19 cases may not need to isolate under the new regulations that are being considered by the National Cabinet. The latest information provided by the Australian Health Protection Principal Committee (AHPPC) on Omicron and any